Chinese english Germany Japanese Korea

Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI)

Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI) Struktur
221229-74-9
CAS-Nr.
221229-74-9
Englisch Name:
Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI)
Synonyma:
LNA-N4-Bz-C;2'-O-4'-C-Locked-rC(Bz);N4-Benzoyl-2’-O,4’-C-methylenecytidine;N4-Benzoyl-2’-O,4’-C-methylenecytidine;Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI);Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI)
CBNumber:
CB08381477
Summenformel:
C17H17N3O6
Molgewicht:
359.33
MOL-Datei:
221229-74-9.mol
Request For Quotation

Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI) Eigenschaften

Schmelzpunkt:
221-223 °C (decomp)
Dichte
1.63±0.1 g/cm3(Predicted)
pka
8.60±0.20(Predicted)

Sicherheit

Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI) Chemische Eigenschaften,Einsatz,Produktion Methoden

Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Jinan Carbotang Biotech Co.,Ltd. 		+8615866703830
 figo.gao@foxmail.com China 8497 58
NewCan Biotech Limited 		+86-0571-86912261 +8613735419629
 sales@newcanbio.com China 9980 58
Allbiosyn Biotechnology Co.,Ltd. 		+8618666985712
 info@allbiosyn.com China 286 58
Nanjing Baifuli Technology Co., Ltd. 25-25-58740604 15951658055
 sales@unisyn.cn China 561 58
Jinan Kabotang Biological Technology Co.,Ltd. 0531-61320525 15866703830
 495745175@qq.com China 7989 58
Zhengzhou Granlen Sciences, ltd. 0371-85513397
info@granlen.com China 1842 58
Allbiosyn Biotechnology Co.,LTD 18666985712
 info@allbiosyn.com China 285 58
  • Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI)
  • N4-Benzoyl-2’-O,4’-C-methylenecytidine
  • LNA-N4-Bz-C
  • Cytidine, N-benzoyl-2'-O,4'-C-methylene- (9CI)
  • N4-Benzoyl-2’-O,4’-C-methylenecytidine
  • 2'-O-4'-C-Locked-rC(Bz)
  • 221229-74-9
Copyright 2019 © ChemicalBook. All rights reserved